Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes
Rural-based charities a little richer with the help of Canadian farmers and the Bayer Fund’s Canada’s Farmers Grow Communities Program
The American Society of Nephrology (ASN)’s Kidney Week 2021:
New analyses of the comprehensive finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D, independent of baseline therapy
Bayer Fund supports future agriculture leaders with $93,000 in Post-secondary scholarship funding